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Would NIH have funded Darwin? 
 
 
 
It is scarcely controversial, at least among 
scientists, that evolution is the key construct in 
biology. Research on genetic manipulation is 
now an important component of NIH’s portfolio. 
But would NIH have supported development of 
the underlying theory? In the days of the 
gentleman scientist, young Charles Darwin was 
supported by family funds. But those days are 
over. Imagine how Darwin’s application would 
have fared in today’s review process (Specific 
Aims: (1) Sail to the tropics (2) Collect fossils 
(3) Construct a story about natural selection) 
 
My sense is that NIH funds work for which 
applications must be readily apparent. 
Furthermore, it seems virtually impossible for 
them to fund theory development. They interpret 
their charge, to improve the nation’s health, to 
mean that they must focus on interventions that 
promise demonstrable changes in health status. 
In contrast, the development of an important 
theory in physics is considered worthwhile even 
if the theorist does not include an empirical test 
in his or her presentation. 
 
Max Planck's quantum theory, published in 
1900, had no supporting evidence until Robert 
Milliken's oil-drop experiment appeared in 1911. 
Surely Milliken was inspired by the theory that 
he had read about. Eventually, both Planck and 
Milliken won Nobel prizes in physics for their 
work.  
 
String theory has been around for some 20 years, 
and continues to draw massive funding from 
NSF, even though its proponents admit that the 
evidence to support it will not be forthcoming 
until technological advances are made. Almost 
surely, those advances will come from folks not 
associated with the development of the theory 
itself. The physics community recognizes that 
people who develop theories are not necessarily 
skilled experimentalists who can provide 
evidence, and also that some theories will not be 
testable now.  
 
Of course, NIH cannot afford simply to fund 
anyone who promises to present a great idea. 
Fortunately, there is already a place a model for 
how to fund the development of theory, and it 
might be worthwhile for NIH to explore how 
NSF handles that responsibility. 
 
 
 
Editor, 
Jie Weiss 
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